Biafungin (CD101), a Novel Echinocandin, Displays an Uncommonly Long Half-life in Multiple Species

Background: The echinocandins are an important class of antifungal agents, but areadministered once daily by intravenous (IV) infusion. An echinocandin that offers a convenientand more economic dosing schedule is desired.Biafungin is a highly stable echinocandin for intermittent IV administration. The compound wasfound to have a long half-life (T1/2), which may greatly reduce costs even as an IV therapythrough less frequent dosing, allowing earlier discharges for patients with negative fungal
Source: The Aspergillus Website - updates - Category: Respiratory Medicine Authors: Source Type: news